4.8 Article

Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study

Krzysztof Tomasiewicz et al.

Summary: The study suggests that tocilizumab can effectively control the symptoms of severe COVID-19 by reducing the inflammatory response and rapidly improving the clinical status in most patients.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)

Article Virology

The association of interleukin-6 value, interleukin inhibitors, and outcomes of patients with COVID-19 in New York City

Tetsuro Maeda et al.

Summary: This study found that IL-6 inhibitor tocilizumab did not reduce in-hospital mortality in severe cases of COVID-19, with age, peak IL-6, and peak d-dimer levels being significant predictors of in-hospital mortality.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Serum as Predictor of Severe Outcome in Coronavirus Disease 2019: A Retrospective Cohort Study

Karl Hagman et al.

Summary: Detection of SARS-CoV-2 RNA in serum at hospital admission is associated with a higher risk of progression to critical disease and death in COVID-19 patients. Positive results indicate a poorer outcome.

CLINICAL INFECTIOUS DISEASES (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Diagnostic Performance of Chest CT for SARS-CoV-2 Infection in Individuals with or without COVID-19 Symptoms

Kristof De Smet et al.

Summary: The use of chest CT with Coronavirus Disease 2019 Reporting and Data System (CO-RADS) classification showed good diagnostic performance in symptomatic individuals, but was not sensitive enough for asymptomatic individuals, suggesting its limited application as a first-line screening tool. Incidental detection of CO-RADS 3 or greater in asymptomatic individuals should prompt testing for respiratory pathogens.

RADIOLOGY (2021)

Letter Infectious Diseases

SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality

Mina T. Kelleni

JOURNAL OF INFECTION (2021)

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Article Virology

Transmission dynamics and evolutionary history of 2019-nCoV

Xingguang Li et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Editorial Material Medicine, General & Internal

Emerging understandings of 2019-nCoV

[Anonymous]

LANCET (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia

Fengxiang Song et al.

RADIOLOGY (2020)

Article Immunology

Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19

H. Hou et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

IL-6: Relevance for immunopathology of SARS-CoV-2

E. O. Gubernatorova et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Article Infectious Diseases

2019 novel coronavirus (2019-nCoV) outbreak: A new challenge

Tommaso Lupia et al.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)

Review Biochemistry & Molecular Biology

SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment

Marcella Prete et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Letter Critical Care Medicine

SARS-CoV-2 viral load predicts COVID-19 mortality

Elisabet Pujadas et al.

LANCET RESPIRATORY MEDICINE (2020)

Editorial Material Allergy

Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection

Brian Lipworth et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

Article Allergy

IL-6-based mortality risk model for hospitalized patients with COVID-19

Rocio Laguna-Goya et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Infectious Diseases

SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients

Cuiyan Tan et al.

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2020)

Editorial Material Multidisciplinary Sciences

How does SARS-CoV-2 cause COVID-19?

Nicholas J. Matheson et al.

SCIENCE (2020)

Article Pharmacology & Pharmacy

Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Tomas Palanques-Pastor et al.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2020)

Editorial Material Medicine, Research & Experimental

Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum

Jill E. Weatherhead et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Cardiac & Cardiovascular Systems

Brief annotations on cytokine release syndrome and interleukin-6 therapeutic blockage in SARS- CoV-2/COVID-19

Luis M. Amezcua-Guerra

ARCHIVOS DE CARDIOLOGIA DE MEXICO (2020)

Letter Critical Care Medicine

Inhibiting IL-6 in COVID-19: we are not sure

Patrick M. Honore et al.

CRITICAL CARE (2020)

Article Medicine, General & Internal

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Ali Moh Zaki et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

C Drosten et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)